Condensed Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2022	$ 243,376	$ 7	$ 522,945	$ (378)	$ (279,198)
Balance, shares at Dec. 31, 2022		66,857,113
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, shares		8,311
Vesting of early exercised stock options	1		1
Stock-based compensation	3,514		3,514
Other comprehensive income (loss)	258			258
Net loss	(31,737)				(31,737)
Balance at Mar. 31, 2023	215,412	$ 7	526,460	(120)	(310,935)
Balance, shares at Mar. 31, 2023		66,865,424
Balance at Dec. 31, 2022	243,376	$ 7	522,945	(378)	(279,198)
Balance, shares at Dec. 31, 2022		66,857,113
Net loss	(65,006)
Balance at Jun. 30, 2023	189,940	$ 7	534,470	(333)	(344,204)
Balance, shares at Jun. 30, 2023		67,865,158
Balance at Mar. 31, 2023	215,412	$ 7	526,460	(120)	(310,935)
Balance, shares at Mar. 31, 2023		66,865,424
Issuance of common stock in connection with at-the-market sales, net of issuance costs	3,868		3,868
Issuance of common stock in connection with at-the-market sales, net of issuance costs, shares		535,767
Issuance of common stock pursuant to employee stock purchase plan	282		282
Issuance of common stock pursuant to employee stock purchase plan, shares		150,575
Issuance of common stock upon exercise of pre-funded warrants, shares		302,517
Issuance of common stock upon exercise of stock options	29		29
Issuance of common stock upon exercise of stock options, shares		10,875
Stock-based compensation	3,831		3,831
Other comprehensive income (loss)	(213)			(213)
Net loss	(33,269)				(33,269)
Balance at Jun. 30, 2023	189,940	$ 7	534,470	(333)	(344,204)
Balance, shares at Jun. 30, 2023		67,865,158
Balance at Dec. 31, 2023	139,424	$ 7	542,805	(106)	(403,282)
Balance, shares at Dec. 31, 2023		68,330,342
Issuance of common stock and pre-funded warrants, net of issuance costs	46,762	$ 1	46,761
Issuance of common stock and pre-funded warrants, net of issuance costs, shares		8,888,890
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, shares		246,708
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	11		11
Issuance of common stock upon exercise of pre-funded warrants	1		1
Issuance of common stock upon exercise of pre-funded warrants, shares		1,051,594
Stock-based compensation	4,224		4,224
Other comprehensive income (loss)	(14)			(14)
Net loss	(32,228)				(32,228)
Balance at Mar. 31, 2024	158,180	$ 8	593,802	(120)	(435,510)
Balance, shares at Mar. 31, 2024		78,517,534
Balance at Dec. 31, 2023	139,424	$ 7	542,805	(106)	(403,282)
Balance, shares at Dec. 31, 2023		68,330,342
Net loss	(61,659)
Balance at Jun. 30, 2024	133,997	$ 8	598,997	(67)	(464,941)
Balance, shares at Jun. 30, 2024		78,867,437
Balance at Mar. 31, 2024	158,180	$ 8	593,802	(120)	(435,510)
Balance, shares at Mar. 31, 2024		78,517,534
Issuance of common stock pursuant to employee stock purchase plan	554		554
Issuance of common stock pursuant to employee stock purchase plan, shares		320,951
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, shares		28,952
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	30		30
Stock-based compensation	4,611		4,611
Other comprehensive income (loss)	53			53
Net loss	(29,431)				(29,431)
Balance at Jun. 30, 2024	$ 133,997	$ 8	$ 598,997	$ (67)	$ (464,941)
Balance, shares at Jun. 30, 2024		78,867,437